Your email has been successfully added to our mailing list.

×
-0.017467248908297 0.00436681222707434 -0.00262008733624445 -0.0305676855895196 -0.074235807860262 -0.0917030567685589 -0.0611353711790394 -0.0611353711790394
Stock impact report

Biomerica gets first commercial order for H. pylori test [Seeking Alpha]

Biomerica, Inc. (BMRA) 
NASDAQ:AMEX Investor Relations: biomerica.com/company/investor.asp
Company Research Source: Seeking Alpha
The initial order had been for the UK market following MHRA clearance in Feb. 2026 The company had seen the deal as a key step in expanding commercialization across Europe Order had been expected to support further distribution partnerships in U.S. and EU markets Shares +4.00%. Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up More on Biomerica Financial information for Biomerica Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
BMRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
BMRA alerts

from News Quantified
Opt-in for
BMRA alerts

from News Quantified